TABLE 3

Treatments used in generation gene expression profiles

Chemicals and physiological conditions that were used in generating the first phase of experiments for the EDGE database. Experiments listed are performed on C57Bl/6 male mice. The exception is the male liver RNA compared with female RNA. More detailed information regarding experimental conditions is available on the EDGE Web site at edge.oncology.wisc.edu

Chemical Route Dose Time Mechanism
Acetominaphen p.o. 400 mg/kg 1 day Electrophile
TCDD p.o. 10 μg/kg 2 days AHR agonist
3-Methylcholanthrene i.p. 100 mg/kg 2 days AHR agonist
β-Napthoflavone p.o. 100 mg/kg 2 days AHR agonist
Aroclor 1260 i.p. 200 mg/kg 2 days AHR agonist
Phenobarbital p.o. 100 mg/kg/day 2 days CAR agonist
TCPOBOP i.p. 3 mg/kg/day 2 days CAR agonist
Circadian rhythm None None 0, 4, 8, 12, 16, 24 h Circadian
Ketoconazole i.p. 250 mg/kg 1, 4 days P450 inducer
Cobalt p.o. 60 mg/kg 2 days Heme disrupter
Phenylhydrazine p.o. 100 mg/kg 2 days Heme disrupter
DEHP Chow 2% 2 weeks PPAR agonist
Ciprofibrate Chow 0.1% 2 weeks PPAR agonist
Wy-14,643 Chow 0.1% 2 weeks PPAR agonist
Corn oil p.o. 1 μl/g 2 days Vehicle
Corn oil i.p. 1 μl/g 2 days Vehicle
DMSO i.p. 1 μl/g 2 days Vehicle
Saline p.o. 1 μl/g 2 days Vehicle
Lipopolysaccharide i.p. 1 mg/kg 6, 12, 24, 48 h Inflammatory agent
Interleukin-1β i.p. 25 μg/kg 6 h Inflammatory response
Interleukin-6 i.p. 25 μg/kg 6 h Inflammatory response
Tumor necrosis factor-α i.p. 5 g/kg 6, 12 h Inflammatory response
Fasting None None 1, 2 days Metabolism
Sex None None None Sex
  • AHR, aryl hydrocarbon receptor; DEHP, diethyl-hexyl-phthalate; TCPOBOP, 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene.